Mavenclad Overdosage

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Presentation/Packing

Full Prescribing Info

Overdosage

There is limited experience with overdose of MAVENCLAD. Lymphopenia is known to be dose-dependent (refer to Precautions and Adverse Reactions).
There is no known specific antidote to an overdose of MAVENCLAD. Treatment consists of careful observation and initiation of appropriate supportive measures. Discontinuation of MAVENCLAD may need to be considered. Because of the extensive intracellular and tissue distribution, haemodialysis is unlikely to eliminate cladribine to a significant extent.
Particularly close monitoring of haematological parameters is recommended in patients who have been exposed to an overdose of MAVENCLAD.

cladribine

Manufacturer:

Merck

Distributor:

Apex Pharma Marketing